Matches 1 - 50 out of 337 1 2 3 4 5 6 7 >


Match Document Document Title
US20150259739 DETERMINING AGE RANGES OF SKIN SAMPLES  
The present invention provides methods for characterizing a skin sample of a subject as belonging to an age range by analyzing nucleic acid or protein molecules obtained from the subject. The...
US20110038953 STRONTIUM COMPOUND FOR TREATMENT OF SUB-DERMAL SOFT TISSUE PAIN  
The invention provides a method of treatment of a human or non-human subject to combat sub-dermal soft tissue pain therein, said method comprising administering to a subject in need thereof an...
US20110097401 METHODS FOR TREATING GASTROINTESTINAL DISORDERS  
Provided herein are compositions and formulations suitable for the treatment of gastrointestinal disorders. Also provided are methods for treating, preventing, or alleviating disorders of the...
US20100203166 METHODS OF PREVENTING RESPIRATORY INFECTIONS  
Methods for inhibiting the development of respiratory infections in humans are disclosed. One embodiment of the methods comprises pouring a predetermined amount of an oral rinse, capable of...
US20120058199 COMPOSITIONS, USE AND METHOD FOR THE USE OF SURFACE ACTIVE PROTEINS IN TOPICAL DRUG DELIVERY ACROSS KERATIN  
The present invention provides the use of surface active proteins, especially class I and class II hydrophobins, in topically applied pharmaceutical formulations. The invention is particularly...
US20120148690 SKIN BARRIER FUNCTION RECOVERY ACCELERATOR  
A novel skin barrier function recovery acceleration method and accelerator are provided. The present invention provides a skin barrier function recovery accelerator that comprises a TRPA1 agonist...
US20100310680 COMPOSITION AND METHOD FOR TREATING ACNE  
This invention relates to a novel composition and method useful for the treatment of acne, and more particularly, to a composition and method for reducing an appearance of post acne marks and...
US20110256249 HAIR AND SCALP CARE FORMULATIONS FOR TREATING AND PREVENTING ACNE AND RELATED SKIN CONDITIONS  
The present invention is directed to skin treatment formulations having salicylic acid and other secondary ingredients. The secondary ingredients may include: non-comedogenic essential oils and...
US20120183591 Surfactant Mixtures for Improving the Deposition of Active Substances and for Reducing the Skin Irritant Action  
A cosmetic or pharmaceutical rinse-off formulation contains 0.2% by weight to 20% by weight of a phase A; 0.1% by weight to 50% by weight of an active substance; a detergent; and the remainder...
US20090298796 REDUCING RISK OF TYPE 2 DIABETES (T2D)  
This invention relates to methods for reducing chronic subacute inflammatory states associated with obesity and improve glycemia, thereby preventing or delaying the development of type 2 diabetes...
US20110300085 Home And Personal Care Compositions  
The present invention relates to home and personal care compositions comprising a silicone oil-in-water emulsion stabilized by a protein or peptide and at least one home and/or personal care...
US20110033402 Solubilized benzoyl small molecule  
The invention relates to a novel solubilized small molecule topical formulation for the transdermal delivery of small molecule agents comprising: a small molecule agent, one or more micelle...
US20120107428 REPELLENTS FOR PESTIFEROUS SOCIAL WASPS  
Provided herein are essential oils and synthetic compounds, and combinations thereof, as repellent compositions for repelling insects, such as vespid social wasps (Vespidae), including...
US20110076261 Antifungal Drug Delivery System  
A topical treatment for skin disorders and diseases comprising a combination of at least one antifungal agent and at least one hydroxy acid agent having a pH−pKa value of 0.5 or more formulated...
US20110183019 METHODS OF SCREENING FOR AND TREATING AUTISM SPECTRUM DISORDERS AND COMPOSITIONS FOR SAME  
Disclosed are methods of screening for an autism spectrum disorder, compositions that inhibit the release of molecules that disrupt the blood-brain barrier, compositions for treating autism...
US20150154881 Method for a Wellbeing Therapy Program  
As one implementation example, a method for comforting and helping an addicted user is described which comprises referencing a first portion of an informational composition, the first portion...
US20110160166 Therapeutic composition for the treatment and prevention of athlete's foot and fungal infections of the nail and surrounding tissues  
Methods and topical pharmaceutical formulations are provided for the treatment of athlete's foot (tinea pedis) and nail fungus (onychomycosis). The invention involves an anhydrous composition...
US20140205682 METHOD BASED ON BISMUTH ION FOR THE TREATMENT AND PREVENTION OF A DISEASE CAUSED BY A SHIGA TOXIN  
The present invention relates to the a bismuth-based composition, particularly involving the use of bismuth ions, particularly the Bi+3 ion, for prevention and/or treatment of the haemolytic...
US20070004686 Attractant for apple fruit moth and other insect pests of apple  
The present invention relates to the use of behaviour modifying volatile plant compounds of rowan Sorbus aucuparia and apple Malus domestica for a determination of a population or controlling pest...
US20120114670 METHODS AND COMPOSITIONS RELATED TO SYNERGISTIC RESPONSES TO ONCOGENIC MUTATIONS  
Disclosed are compositions and methods related to new targets for cancer treatment.
US20120082659 Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations  
Disclosed are compositions and methods related to new targets for cancer treatment.
US20150140133 IN SITU CONTROLLED RELEASE DRUG DELIVERY SYSTEM  
A system is described for long-term controlled release delivery of a drug or a therapeutic agent. According to the invention, one or more drugs or therapeutic agents contained in microspheres are...
US20130029922 FORMULATIONS FROM NATURAL PRODUCTS, TURMERIC, PACLITAXEL, AND ASPIRIN  
The invention provides novel compounds and formulations of turmeric oil, fish oil, aspirin and anti-cancer drugs (paclitaxel) having anti-inflammatory, analgesic and/or anti-cancer activity.
US20070141182 Combination of multiple nonteroidal antiinflammatory drugs and muscle relaxants for local treatment of musculoskeletal pain  
This invention relates to pharmaceutical compositions for use in the treatment of pain and inflammation and the treatment of muscle spasms and associated pain, soreness and tightness of muscles in...
US20120128753 MEDITOWEL PRE-PACKAGED MEDICATED MUSCLE AND JOINT PAIN RELIEF WIPE  
Single use, substrate uniformly impregnated with an anhydrous muscle and joint pain relief solution for the use of aseptically delivering a single dose of a muscle and joint pain relief solution...
US20120309623 SURFACE-MODIFIED HYDROGELS AND HYDROGEL MICROPARTICLES  
Provided in various embodiments are surface-modified hydrogels and hydrogel microparticles, methods for their preparation, and uses thereof for delivery of personal care and healthcare active...
US20110294762 GLYCERYL AND GLYCOL ACID COMPOUNDS  
A composition comprising a glyceryl salicylate compound and/or a glycol salicylate compound. The compositions can be used to reduce the amount of moisture evaporated from skin, protect the skin...
US20150080352 AQUEOUS POLYURETHANE DISPERSION IN THE TREATMENT OF ACNE  
The present invention describes a surprising effect of an aqueous polyurethane dispersion on the efficacy of active ingredients in the anti-acne treatment. The aqueous polyurethane dispersion was...
US20110070224 METHODS COMPOSITIONS AND DEVICES UTILIZING STINGING CELLS/CAPSULES FOR DELIVERING A THERAPEUTIC OR A COSMETIC AGENT INTO A TISSUE  
A delivery device including at least one stinging capsule and methods of use are described.
US20080138422 Analgesic Compositions  
The present invention relates to pharmaceutical compositions comprising an analgesic agent and providing controlled release of the agent for improved treatment and prevention of pain and...
US20140303074 Compositions and Methods For Inhibiting Immunodeficiency Virus Transcription  
The present disclosure provides methods of reducing immunodeficiency virus transcription, involving use of diflunisal or an active ester thereof. The disclosure also provides methods of treating...
US20060078596 Treatment of muscle fatigue  
The present invention involves the use of a compound that reduces the level of free fatty acids circulating in the plasma of a subject in the manufacture of a medicament for the treatment of...
US20080031833 Combined energy and topical composition application for regulating the condition of mammalian skin  
Method for regulating the condition of mammalian skin comprising the steps of applying a first personal care composition to an area of skin where regulation is desired, wherein the first personal...
US20110244045 CONTROLLED RELEASE OF N-ACETYLCYSTEINE (NAC) FOR REDUCTION OF SYSTEMIC AND/OR VASCULAR INFLAMMATION  
The present invention provides a controlled-release composition which provides a therapeutically effective plasma concentration of N-acetylcysteine over prolonged period of time. The present...
US20070275096 Composition and methodology for the treatment of hearing impairment symptoms  
One possible embodiment of the invention could include a homeopathic composition suitable for the treatment of the symptoms of hearing impairment comprises: 3-Isothiocyanato-1-Propene in 6 times...
US20110076250 Biodegradable Absorbents and Methods of Preparation  
A biodegradable microfiber absorbent comprises a substantially homogeneous mixture of at least one hydrophilic polymer and at least one biodegradable polymer. The absorbent can be prepared by an...
US20150071864 REVERSELY THERMO-REVERSIBLE HYDROGEL COMPOSITIONS  
A reversely thermo-reversible hydrogel composition comprising a water soluble block copolymer comprising at least two blocks of polyethylene oxide and at least one block of polypropylene oxide,...
US20120244097 REVERSELY THERMO-REVERSIBLE HYDROGEL COMPOSITIONS  
A reversely thermo-reversible hydrogel composition comprising a water soluble block copolymer comprising at least two blocks of polyethylene oxide and at least one block of polypropylene oxide,...
US20130157985 PAIN RELIEF COMPOSITIONS, MANUFACTURE AND USES  
The present invention relates to TRPV1 selective agonist topical compositions including capsaicinoid and analgesic agent compositions and methods of manufacture and methods of providing pain...
US20150133406 SYNERGISTIC FORMULATIONS FOR CONTROL AND REPELLENCY OF BITING ARTHROPODS  
Control or repellency of biting arthropods, particularly biting insects, is accomplished by bringing the biting arthropods into contact with combinations of compounds identical or related to those...
US20110269697 ORGANOARSENIC COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER  
A method for treating a lymphoma selected from non-Hodgkin's and Hodgkin's lymphoma comprising administering an organoarsenic compound having a structure of the formula (I) wherein X is S or Se...
US20090270354 Method of removing ticks from the skin and reducing the risk of bites  
Compositions and method of using the same for the removal of ticks embedded in the skin or tissue of a human or animal host and for preventing ticks from attaching themselves to and biting humans...
US20120064136 ANTI-AGING AND WRINKLE TREATMENT METHODS USING NANOEMULSION COMPOSITIONS  
The present invention relates to methods for treating, preventing, minimizing, and/or diminishing signs of aging in the skin comprising administering to the subject in need thereof a nanoemulsion...
US20090169644 Antidandruff Shampoo  
Surfactant-containing cleansing compositions contain hydrogenated castor oil for stabilizing an antidandruff component that is insoluble in the cleansing composition. As a result, thorough and...
US20120070507 Compositions and Methods for the Treatment of Soft Tissue Injury  
Provided herein are compositions and methods for the treatment of soft tissue injury, sports-related injury, physical overuse of muscles, ligaments or joints, and trauma, traumatic stress or...
US20110034423 METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS  
The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit...
US20110027201 METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS  
The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit...
US20090088400 PROSTAGLANDIN E2 MODULATION AND USES THEREOF  
Methods, uses, kits and products are described for the prognosis, diagnosis, prevention and treatment of myotronic dystrophy type 1 (DM1), and more particularly for the prognosis, diagnosis,...
US20110130369 USE OF FTS FOR THE TREATMENT OF MYOCARDIAL ISCHEMIA/REPERFUSION INJURY  
Disclosed are methods for reducing the extent of myocardial ischemia/reperfusion injury, comprising administering to a human prior to reperfusion of the ischemic myocardium or pre-angioplasty,...
US20140199400 Active Agent Loaded Uniform, Rigid, Spherical, Nanoporous Calcium Phosphate Particles and Methods of Making and Using the Same  
Uniform, rigid, spherical nanoporous calcium phosphate particles that define an internal space and an amount of active agent present in the internal space are provided. Also provided are topical...

Matches 1 - 50 out of 337 1 2 3 4 5 6 7 >